Evidence map›Paper›PMID 31286192›Full record

ReviewZeitschrift fur Rheumatologie2019

[Rheumatological care in the Rheumazentrum Ruhrgebiet Rheumatism Center-a model for conurbations].

J Braun, U Kiltz, I Andreica, B Buehring, B Guminski, U Häusler, H Kavruk, D Kiefer, R Lochowski, B Mintrop and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Zeitschrift fur Rheumatologie, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

J BraunRheumazentrum Ruhrgebiet, Marienhospital Herne, Ruhr Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland. juergen.braun@elisabethgruppe.de.
U KiltzRheumazentrum Ruhrgebiet, Marienhospital Herne, Ruhr Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland.
I AndreicaRheumazentrum Ruhrgebiet, Marienhospital Herne, Ruhr Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland.
B BuehringRheumazentrum Ruhrgebiet, Marienhospital Herne, Ruhr Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland.
B GuminskiRheumazentrum Ruhrgebiet, Marienhospital Herne, Ruhr Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland.
U HäuslerRheumazentrum Ruhrgebiet, Marienhospital Herne, Ruhr Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland.
H KavrukRheumazentrum Ruhrgebiet, Marienhospital Herne, Ruhr Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland.
D KieferRheumazentrum Ruhrgebiet, Marienhospital Herne, Ruhr Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland.
R LochowskiRheumazentrum Ruhrgebiet, Marienhospital Herne, Ruhr Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland.
B MintropRheumazentrum Ruhrgebiet, Marienhospital Herne, Ruhr Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland.
X BaraliakosRheumazentrum Ruhrgebiet, Marienhospital Herne, Ruhr Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland.
Ruhr University Bochum · DERheumazentrum Ruhrgebiet · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Ruhrgebiet Rheumatism Center, which is highly specialized for rheumatic diseases, is the largest of its kind in Germany. For many years it has fulfilled all the requirements for structural quality required by the Association of Rheumatological Acute Clinics (VRA) including regular participation in the KOBRA benchmarking project. Therefore, the center regularly receives the VRA seal for quality of care. In 2018 more than 7500 patients were treated as inpatients. Within the framework of care according to §116b (ASV since May 2019) there were nearly 25,000 outpatient patient contacts. Furthermore, an early screening program (triage) was established 5 years ago in order to be able to identify patients with musculoskeletal complaints on a potentially inflammatory rheumatic basis. This functions in the sense of an early diagnosis and treatment in accordance with the treat-to-target concept within less than 4 weeks (initially) on an outpatient basis with respect to the required urgency, in order to subsequently provide sound diagnostic support. In the last 2 years 2017 and 2018, this deadline was met in more than 90% of cases. Within the scope of inpatient care approximately one third of patients were treated in recent years with a defined rheumatological complex therapy and 10% with pain complex therapy. Approximately 3% were treated with geriatric complex therapy and 65% were short-stay patients (<4 days), i.e. patients who received the necessary diagnostics and treatment on an inpatient basis at short notice. The overall structure of the rheumatism center, the cooperation with rheumatologists in private practice, many cooperation partners, referring physicians and patients represents a model for rheumatological care in large conurbations. The care of large numbers of patients also enables the further training of many assistants and this is essential for the future of good rheumatological medicine.

Indexed as

Quality Assurance, Health CareRheumatic DiseasesRheumatologyEarly DiagnosisGermanyHumansRheumatologistsComplex therapyInpatient careOutpatient careQualityTreat-to-target

Identifiers

PMID31286192
OpenAlexW2960603579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.